Netherlands: A randomized trial published in the Gut suggests that smartphone-based self-guided hypnotherapy may help reduce abdominal pain associated with irritable bowel syndrome (IBS). The digital intervention offers a convenient, accessible, and non-drug approach that patients can use independently at home. These findings highlight the potential of mobile health therapies as an effective adjunct for managing IBS symptoms, although further studies are needed to confirm long-term benefits and broader clinical applicability.

Hypnotherapy is recommended in current clinical guidelines as a brain-gut behavioral therapy for IBS. However, access to therapist-led treatment remains limited because of the shortage of trained hypnotherapists and the costs associated with repeated in-person sessions. To address this challenge, researchers led by Johanna T. W. Snijkers from the Department of Gastroenterology and Hepatology, Maastricht University Medical Centre+, the Netherlands, evaluated whether a smartphone-based hypnotherapy program could provide comparable symptom relief.
The multicentre, three-arm randomized controlled trial enrolled 230 adults aged 16 to 75 years who met the Rome IV criteria for IBS. Participants were randomly assigned to receive either 12 weeks of therapist-delivered in-person hypnotherapy, smartphone-based self-guided hypnotherapy, or online self-guided psychoeducation, which served as the control intervention.
The primary outcome was the abdominal pain response, defined by the US Food and Drug Administration (FDA) as at least a 30% reduction in the weekly average of the worst daily abdominal pain during at least two of four follow-up weeks.
Key Findings:
  • At 16 weeks, the FDA-defined abdominal pain response was achieved by 48% of patients receiving therapist-delivered hypnotherapy, 33% receiving smartphone-based self-guided hypnotherapy, and 22% receiving online psychoeducation.
  • Smartphone-based self-guided hypnotherapy improved abdominal pain but did not meet the predefined criteria for non-inferiority compared with therapist-delivered hypnotherapy.
  • No significant differences in psychological symptoms were observed between the three treatment groups.
  • At the six-month follow-up, both therapist-delivered and smartphone-based hypnotherapy remained more effective than online psychoeducation, indicating sustained treatment benefits.
The researchers noted that this is the first randomized controlled trial to compare smartphone-based self-guided hypnotherapy with therapist-delivered hypnotherapy while including an active online control group. Although in-person hypnotherapy was more effective in reducing IBS-related abdominal pain, the smartphone-based program produced clinically meaningful benefits in a substantial proportion of patients.
They concluded that smartphone-based self-guided hypnotherapy could provide a practical, accessible, and cost-effective treatment option for patients who have limited access to certified therapists or prefer flexible home-based care. They added that the approach may be particularly beneficial for individuals with higher digital health literacy and self-management skills, while emphasizing the need for further research to confirm its role in routine clinical practice.
Reference:
Snijkers JTW, Bosman MHMA, Winkens B, et alIn-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial. Gut Published Online First: 25 July 2026. doi: 10.1136/gutjnl-2026-338385
Tags:    
Article Source : BMJ journal Gut

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .